Answers are grounded in this paper and cite their sources.
Vaccination with plasmid DNA is an active area of investigation that is being applied to diseases including cancer and microbial pathogens associated with infectious diseases. Since its discovery, great progress has been made with the administration of DNA vaccines to initiate specific and effective immune responses against targeted illnesses. However, many obstacles still face its use in prophylactic and therapeutic vaccination scenarios. The nature of these difficulties alongside the successes and future of plasmid DNA will be discussed.
No takes yet. Share an insight, caveat, or question.
Lowe et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: